Gut bacteria may influence immunotherapy success in mesothelioma patients

A cancer study has found that certain gut bacteria may influence whether or not a patient’s immune system is successful in fighting mesothelioma, an aggressive form of cancer.

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

Promising results with an investigational CAR T-cell therapy in triple-negative breast cancer and non-small cell lung cancer (NSCLC) were tempered by an unexplained death in

June 29, 2024

Blood test predicts MS disability worsening up to two years in advance

Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later, according to

November 7, 2023

Osteoarthritis may be treatable and reversible, new study shows

Current osteoarthritis treatment manages symptoms rather than addressing the underlying disease, but a new University of Adelaide study has shown the condition may be treatable

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.